» Articles » PMID: 20675669

A Randomized Trial of the Effects of Exercise Training in Chagas Cardiomyopathy

Overview
Publisher Wiley
Date 2010 Aug 3
PMID 20675669
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The effects of exercise training in chronic heart failure are well established, however, they have not been evaluated in Chagas cardiomyopathy (ChC). We sought to determine the effects of exercise training on functional capacity, health-related quality of life (HQoL), and brain natriuretic peptide (BNP) levels in patients with ChC.

Methods And Results: This randomized, controlled, single-blind trial included 40 patients with ChC (age 49.5 +/- 7.8 years, 57.5% male) who did not practice regular exercise. All patients were assessed, at baseline and at the end of the study, by exercise test (VO(2) and exercise time), six-minute walk test (6MWT), Goldman Specific Activity Scale (SAS), HQoL, and BNP levels. Patients were randomized to inactive control group (ICG = 19) or exercise training group (ETG = 21). Exercise training group patients underwent 12 weeks of exercise training: walking for up to 30 min (intensity 50-70% HR reserve + HR at rest) and warm-up and cooling-down exercising, three times a week. The data were analysed for delta values (Delta= end - baseline). After intervention, compared with the ICG, the ETG had significant increases in functional parameters including, DeltaVO(2) (6.5 vs. 2.8 mL/kg/min, P = 0.001), Delta exercise time (2.9 vs.1.1 min, P < 0.001), Delta6MWT distance (83.5 vs. 2.0 m, P = 0.001) improved DeltaSAS (8 vs. 1 patient, P = 0.008), and HQoL: Delta domains vitality (7.5 vs. 0 points, P = 0.013), Delta emotional aspects (16.7 vs. 0 points, P = 0.012), and Delta mental health (16.1 vs. 0 points, P = 0.031). There was no difference in BNP levels.

Conclusion: In patients with ChC, exercise training was associated with a major improvement in functional capacity and HQoL without any adverse effects.

Citing Articles

Exercise Training Reduces Inflammation and Fibrosis and Preserves Myocardial Function and Perfusion in a Model of Chronic Chagas Cardiomyopathy.

Damasceno T, Tanaka D, Magnani E, Oliveira R, Pereira D, Vieira-Alves I Arq Bras Cardiol. 2024; 121(8):e20230707.

PMID: 39258653 PMC: 11495816. DOI: 10.36660/abc.20230707.


Cardiac involvement in Chagas disease and African trypanosomiasis.

Sabino E, Nunes M, Blum J, Molina I, Ribeiro A Nat Rev Cardiol. 2024; 21(12):865-879.

PMID: 39009679 DOI: 10.1038/s41569-024-01057-3.


Chagas heart disease is associated with decreased physical activity levels: A cross-sectional analysis.

Ribeiro L, Goncalves T, Paravidino V, Costa H, Rodrigues Junior L, Mazzoli-Rocha F Int J Cardiol Heart Vasc. 2024; 52:101407.

PMID: 38617820 PMC: 11015123. DOI: 10.1016/j.ijcha.2024.101407.


Effect of an exercise-based cardiac rehabilitation program on quality of life of patients with chronic Chagas cardiomyopathy: results from the PEACH randomized clinical trial.

Vieira M, Mendes F, Silva P, da Silva G, Mazzoli-Rocha F, Silvestre de Sousa A Sci Rep. 2024; 14(1):8208.

PMID: 38589582 PMC: 11001987. DOI: 10.1038/s41598-024-58776-3.


Exercise training in chronic Chagas cardiomyopathy: Promising preliminary evidence, but long-term large clinical trials are still needed.

Mazzoli-Rocha F, Mediano M Int J Cardiol Heart Vasc. 2023; 48:101272.

PMID: 37794958 PMC: 10545930. DOI: 10.1016/j.ijcha.2023.101272.